Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pacira Pharmaceuticals Inc (NASDAQ:PCRX)

33.20
Delayed Data
As of Dec 08
 +0.85 / +2.63%
Today’s Change
29.95
Today|||52-Week Range
80.25
-56.77%
Year-to-Date
No recent news for Pacira Pharmaceuticals Inc.

Today’s Trading

Previous close32.35
Today’s open32.15
Day’s range31.15 - 33.40
Volume876,356
Average volume (3 months)829,599
Market cap$1.2B
Dividend yield--
Data as of 12/08/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-43.35%
Earnings growth (next 5 years)+70.00%
Revenue growth (last year)+25.97%
P/E ratioNM
Price/Sales12.74
Price/Book5.60

Competitors

 Today’s
change
Today’s
% change
XNCRXencor Inc+0.15+0.56%
DEPODepomed Inc+0.14+0.70%
TXMDTherapeuticsMD Inc-0.50-7.51%
OPHTOphthotech Corp+1.19+3.44%
Data as of 12/08/2016

Financials

Next reporting dateFebruary 28, 2017
EPS forecast (this quarter)$0.01
Annual revenue (last year)$249.0M
Annual profit (last year)$1.9M
Net profit margin0.75%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
David M. Stack
President
James S. Scibetta
Corporate headquarters
Parsippany, New Jersey

Forecasts


Search for Jobs